Kaempferol 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside]



Compound IDCDAMM00901
Common nameKaempferol 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside]
IUPAC name5-[[5-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,4-dihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-3-yl]oxyoxan-2-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid
Molecular formulaC33H38O19

Experimental data

Retention time0.36
Adduct[M+H]+
Actual mz739.211
Theoretical mz739.208
Error3.41
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2128

Identifiers and class information

Inchi keyXFTBRZGXKCHGKC-HLUKUQNVNA-N
SmilesO=C(O)CC(O)(C)CC(=O)OCC1OC(OC=2C(=O)C3=C(O)C=C(OC)C=C3OC2C=4C=CC(O)=CC4)C(OC5OCC(O)(CO)C5O)C(O)C1O
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)10
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)20
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)738.652
Computed dipole moment(dipole)3.735
Total solvent accessible surface area (SASA)984.404
Hydrophobic component of SASA (FOSA)381.608
Hydrophilic component of SASA (FISA)408.898
Pie component of the SASA (PISA)193.898
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1951.22
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)20.9
Free energy of solvation of dipole (dip^2/V)0.0071479
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0561723
Globularity descriptor (glob)0.767119
Predicted polarizability in cubic angstroms (QPpolrz)60.944
Predicted hexadecane/gas partition coefficient (QPlogPC16)22.234
Predicted octanol/gas partition coefficient (QPlogPoct)42.881
Predicted water/gas partition coefficient (QPlogPw)32.615
Predicted octanol/water partition coefficient (QPlogPo/w)0.152
Predicted aqueous solubility (QPlogS)-3.476
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.495
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.417
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.333
Predicted brain/blood partition coefficient (QPlogBB)-5.274
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.109
Predicted skin permeability, log Kp (QPlogKp)-6.452
PM3 calculated ionization potential (IP(ev))9.014
PM3 calculated electron affinity (EA(eV))0.709
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-1.176
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)309.442
Number of nitrogen and oxygen atoms (#NandO)19
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P00918CA2Carbonic anhydrase IIT20401SwissTargetPrediction
P16083NQO2Quinone reductase 2T75498SwissTargetPrediction
P22748CA4Carbonic anhydrase IVT53378SEA
P15121AKR1B1Aldose reductaseT26623SwissTargetPrediction
P60568IL2Interleukin-2T61698SEA
P51812RPS6KA3Ribosomal protein S6 kinase alpha 3T03279SwissTargetPrediction
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P47989XDHXanthine dehydrogenaseT40954SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20401DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P00918CA2
T20401DI0137Essential hypertension[ICD-11: BA00]P00918CA2
T20401DI0166Glaucoma[ICD-11: 9C61]P00918CA2
T20401DI0175Heart failure[ICD-11: BD10-BD1Z]P00918CA2
T20401DI0214Insomnia[ICD-11: 7A00-7A0Z]P00918CA2
T20401DI0372Seborrhoeic dermatitis[ICD-11: EA81]P00918CA2
T75498DI0214Insomnia[ICD-11: 7A00-7A0Z]P16083NQO2
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T26623DI0298Neuropathy[ICD-11: 8C0Z]P15121AKR1B1
T26623DI0366Rheumatoid arthritis[ICD-11: FA20]P15121AKR1B1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T03279DI0249Mature B-cell leukaemia[ICD-11: 2A82]P51812RPS6KA3
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025